250 related articles for article (PubMed ID: 23566145)
1. Nanomedicine and infectious diseases.
Bragg RR; Kock L
Expert Rev Anti Infect Ther; 2013 Apr; 11(4):359-61. PubMed ID: 23566145
[TBL] [Abstract][Full Text] [Related]
2. Theranostic nanomedicine for cancer.
Sumer B; Gao J
Nanomedicine (Lond); 2008 Apr; 3(2):137-40. PubMed ID: 18373419
[No Abstract] [Full Text] [Related]
3. Nanomedicine: novel approaches in human and veterinary therapeutics.
Irache JM; Esparza I; Gamazo C; Agüeros M; Espuelas S
Vet Parasitol; 2011 Aug; 180(1-2):47-71. PubMed ID: 21680101
[TBL] [Abstract][Full Text] [Related]
4. Nanomedicines for Infectious Diseases.
Dube A
Pharm Res; 2019 Mar; 36(4):63. PubMed ID: 30859326
[No Abstract] [Full Text] [Related]
5. Nanomedicine--prospective therapeutic and diagnostic applications.
Emerich DF
Expert Opin Biol Ther; 2005 Jan; 5(1):1-5. PubMed ID: 15709905
[TBL] [Abstract][Full Text] [Related]
6. Nanomedicine: magnetic nanoparticles hit the target.
Amirfazli A
Nat Nanotechnol; 2007 Aug; 2(8):467-8. PubMed ID: 18654342
[No Abstract] [Full Text] [Related]
7. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles.
Liu Y; Miyoshi H; Nakamura M
Int J Cancer; 2007 Jun; 120(12):2527-37. PubMed ID: 17390371
[TBL] [Abstract][Full Text] [Related]
8. Emerging potential of stimulus-responsive nanosized anticancer drug delivery systems for systemic applications.
Ruttala HB; Ramasamy T; Madeshwaran T; Hiep TT; Kandasamy U; Oh KT; Choi HG; Yong CS; Kim JO
Arch Pharm Res; 2018 Feb; 41(2):111-129. PubMed ID: 29214601
[TBL] [Abstract][Full Text] [Related]
9. Recent trends on hydrogel based drug delivery systems for infectious diseases.
Vashist A; Kaushik A; Vashist A; Jayant RD; Tomitaka A; Ahmad S; Gupta YK; Nair M
Biomater Sci; 2016 Oct; 4(11):1535-1553. PubMed ID: 27709137
[TBL] [Abstract][Full Text] [Related]
10. The emerging applications of magnetic nanovectors in nanomedicine.
Seeney CE
Pharm Pat Anal; 2015; 4(4):285-304. PubMed ID: 26174567
[TBL] [Abstract][Full Text] [Related]
11. [Nanomedicine: chance or risk for the patients?].
Kathmann W
Dtsch Med Wochenschr; 2009 May; 134(19):p19. PubMed ID: 19424944
[No Abstract] [Full Text] [Related]
12. Nanomedicine in cancer treatment.
Yih TC; Wei C
Nanomedicine; 2005 Jun; 1(2):191-2. PubMed ID: 17292078
[No Abstract] [Full Text] [Related]
13. Nanomedicine toward 2040.
Richardson JJ; Caruso F
Nano Lett; 2020 Mar; 20(3):1481-1482. PubMed ID: 32118443
[No Abstract] [Full Text] [Related]
14. Focus on nanoparticles for cancer diagnosis and therapeutics.
Lee SB
Nanomedicine (Lond); 2007 Oct; 2(5):647-8. PubMed ID: 17976025
[No Abstract] [Full Text] [Related]
15. Nanodelivery systems for improved topical antimicrobial therapy.
Basnet P; Škalko-Basnet N
Curr Pharm Des; 2013; 19(41):7237-43. PubMed ID: 23489202
[TBL] [Abstract][Full Text] [Related]
16. Emerging nanomedicine opportunities with perfluorocarbon nanoparticles.
Winter PM; Cai K; Caruthers SD; Wickline SA; Lanza GM
Expert Rev Med Devices; 2007 Mar; 4(2):137-45. PubMed ID: 17359221
[TBL] [Abstract][Full Text] [Related]
17. Nanomedicine: sizing up targets with nanoparticles.
Minchin R
Nat Nanotechnol; 2008 Jan; 3(1):12-3. PubMed ID: 18654442
[No Abstract] [Full Text] [Related]
18. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug/gene delivery applications.
Son SJ; Bai X; Lee SB
Drug Discov Today; 2007 Aug; 12(15-16):650-6. PubMed ID: 17706547
[TBL] [Abstract][Full Text] [Related]
19. Sulfur and sulfur nanoparticles as potential antimicrobials: from traditional medicine to nanomedicine.
Rai M; Ingle AP; Paralikar P
Expert Rev Anti Infect Ther; 2016 Oct; 14(10):969-78. PubMed ID: 27494175
[TBL] [Abstract][Full Text] [Related]
20. Nanomedicine for cancer therapy.
Amiji MM
Pharm Res; 2011 Feb; 28(2):181-6. PubMed ID: 20845066
[No Abstract] [Full Text] [Related]
[Next] [New Search]
